Stem Cells & Wnt | 干细胞及 Wnt 通路

N-((3-苯甲酰氨基苯基)氨基甲硫酰基)-3,4,5-三甲氧基苯甲酰胺

MRT-10 (MRT 10)

- 98+%

3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine

KAAD-Cyclopamine (Synonyms: Cyclopamine-KAAD;3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine)

- 98+%

LM-41

LM-41 (TEAD Inhibitor)

3-5days 98+%

H-89

H-89

- 98+%

(2'Z,3'E)-6-溴靛玉红-3′-肟

BIO (GSK-3 Inhibitor IX | 6-bromoindirubin-3-oxime | 6-Bromoindirubin-3'-oxime | MLS 2052 | (2'Z,3'E)-6-Bromoindirubin-3'-oxime | 6-BIO | 6BIO

3-5days 99+%

(3S,4S)-替万替尼

(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198

- 98+%

拉格鲁西布二盐酸盐 | CHIR-99021二盐酸盐 |

Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride

- 98+%

甲磺酸贝舒地尔

Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate)

- 98+%

奈舒地尔甲磺酸盐

Netarsudil dimesylate ( AR-13324 dimesylate)

- 98+%

帕米膦酸

Pamidronic Acid

- 98+%

司马西特

Semagacestat | LY450139

In-stock 98+%

布隆妥珠单抗

Brontictuzumab (Anti-NOTCH1)

3-5days 95+%

万替妥单抗

Vantictumab (Anti-FZD)

3-5days 95+%

他瑞妥单抗

Tarextumab (Anti-NOTCH3)

3-5days 95+%

登赛珠单抗

Demcizumab (Anti-DLL4)

3-5days 95+%

Thiazovivin

Thiazovivin

3-5days 98+%

N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2D]嘧啶-2-基)硫基]乙酰胺

N-(6-Methyl-2-benzothiazolyl)-2-[(3​,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrim​idin-2-yl)thio]-acetamide; IWP-2

In-stock 98+%

(R)-(+)-反式-4-(1-氨基乙基)-N-(4-吡啶基)环己烷甲酰胺二盐酸盐单水合物/反-4-[(1R)-1-氨基乙基]-N-4-吡啶-环己甲酰胺盐酸盐一水合物

Y27632 HCl hydrate | (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate | Y-27632 Dihydrochloride Monohydrate

- 98+%

替格鲁西布 | 泰格列净

Tideglusib (Synonyms: NP031112; NP-12)

- 98+%

维莫德吉

Vismodegib (GDC-0449)

In-stock 98+%